TrialAsian Pacific journal of cancer prevention : APJCP2019

A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.

Ruchirek Kamonrattana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.